Loading…
Gene therapy: Regulations, ethics and its practicalities in liver disease
Gene therapy is a new and promising approach which opens a new door to the treatment of human diseases. By direct transfer of genetic materials to the target cells, it could exert functions on the level of genes and molecules. It is hoped to be widely used in the treatment of liver disease, especial...
Saved in:
Published in: | World journal of gastroenterology : WJG 2008-04, Vol.14 (15), p.2303-2307 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c435t-f71b59473e70262f87f55d64fdea39027a552acb11c48e87012622164c932fbc3 |
---|---|
cites | cdi_FETCH-LOGICAL-c435t-f71b59473e70262f87f55d64fdea39027a552acb11c48e87012622164c932fbc3 |
container_end_page | 2307 |
container_issue | 15 |
container_start_page | 2303 |
container_title | World journal of gastroenterology : WJG |
container_volume | 14 |
creator | Jin, Xi Yang, Yi-Da Li, You-Ming |
description | Gene therapy is a new and promising approach which opens a new door to the treatment of human diseases. By direct transfer of genetic materials to the target cells, it could exert functions on the level of genes and molecules. It is hoped to be widely used in the treatment of liver disease, especially hepatic tumors by using different vectors encoding the aim gene for anti-tumor activity by activating primary and adaptive immunity, inhibiting oncogene and angiogenesis. Despite the huge curative potential shown in animal models and some pilot clinical trials, gene therapy has been under fierce discussion since its birth in academia and the public domain because of its unexpected side effects and ethical problems. There are other challenges arising from the technique itself like vector design, administration route test and standard protocol exploration. How well we respond will decide the fate of gene therapy clinical medical practice. |
doi_str_mv | 10.3748/wjg.14.2303 |
format | article |
fullrecord | <record><control><sourceid>wanfang_jour_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2705082</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>27168178</cqvip_id><wanfj_id>wjg200815002</wanfj_id><sourcerecordid>wjg200815002</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-f71b59473e70262f87f55d64fdea39027a552acb11c48e87012622164c932fbc3</originalsourceid><addsrcrecordid>eNpVkc1u1DAURi0EosPAij2yEGIDGfwbO5tKqIJSUQkJwdpynJuMh4wztZ1WfZU-S9-JV8CjGQFdeeGjc797P4ReUrLiSugPN5thRcWKccIfoQVjtKmYFuQxWlBCVNVwpk7Qs5Q2hDDOJXuKTqgWtBZSLNDXcwiA8xqi3d3-vr_D32GYR5v9FNJ7DHntXcI2dNjnhHfRuuydHX32kLAPePTXEHHnE9gEz9GT3o4JXhzfJfr5-dOPsy_V5bfzi7OPl5UTXOaqV7SVjVAcFGE167Xqpexq0XdgeUOYslIy61pKndCgFaGFYiWvK6v0reNLdHrw7uZ2C52DkKMdzS76rY23ZrLePPwJfm2G6dowRSTRrAjeHAQ3NvQ2DGYzzTGUyKbckhGiqdzfaoneHufE6WqGlM3WJwfjaANMczJ1Q4uN1QV8dwBdnFKK0P_NQonZd7T3GirMvqNCv_o__j_2WEoBXh916ykMV74EbK371fsRygq01lRp_geiPJk7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69108226</pqid></control><display><type>article</type><title>Gene therapy: Regulations, ethics and its practicalities in liver disease</title><source>PubMed Central</source><creator>Jin, Xi ; Yang, Yi-Da ; Li, You-Ming</creator><creatorcontrib>Jin, Xi ; Yang, Yi-Da ; Li, You-Ming</creatorcontrib><description>Gene therapy is a new and promising approach which opens a new door to the treatment of human diseases. By direct transfer of genetic materials to the target cells, it could exert functions on the level of genes and molecules. It is hoped to be widely used in the treatment of liver disease, especially hepatic tumors by using different vectors encoding the aim gene for anti-tumor activity by activating primary and adaptive immunity, inhibiting oncogene and angiogenesis. Despite the huge curative potential shown in animal models and some pilot clinical trials, gene therapy has been under fierce discussion since its birth in academia and the public domain because of its unexpected side effects and ethical problems. There are other challenges arising from the technique itself like vector design, administration route test and standard protocol exploration. How well we respond will decide the fate of gene therapy clinical medical practice.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.14.2303</identifier><identifier>PMID: 18416454</identifier><language>eng</language><publisher>United States: Digestive Department, The First Affiliated Hospital, Medical School, Zhejiang University, Hangzhou 310003,Zhejiang Province, China%China Yi-Da Yang, Infectious disease Department, The First Affiliated Hospital, Medical School, Zhejiang University, Hangzhou 310003,Zhejiang Province, China</publisher><subject>Animals ; Diffusion of Innovation ; Genetic Therapy - adverse effects ; Genetic Therapy - ethics ; Genetic Therapy - legislation & jurisprudence ; Genetic Therapy - trends ; Genetic Vectors ; Government Regulation ; Humans ; Liver Diseases - genetics ; Liver Diseases - therapy ; Liver Neoplasms - genetics ; Liver Neoplasms - therapy ; Review ; Transduction, Genetic ; Treatment Outcome ; 基因治疗 ; 带菌者 ; 肝疾病</subject><ispartof>World journal of gastroenterology : WJG, 2008-04, Vol.14 (15), p.2303-2307</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><rights>2008 The WJG Press and Baishideng. All rights reserved. 2008</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-f71b59473e70262f87f55d64fdea39027a552acb11c48e87012622164c932fbc3</citedby><cites>FETCH-LOGICAL-c435t-f71b59473e70262f87f55d64fdea39027a552acb11c48e87012622164c932fbc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705082/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705082/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18416454$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jin, Xi</creatorcontrib><creatorcontrib>Yang, Yi-Da</creatorcontrib><creatorcontrib>Li, You-Ming</creatorcontrib><title>Gene therapy: Regulations, ethics and its practicalities in liver disease</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>Gene therapy is a new and promising approach which opens a new door to the treatment of human diseases. By direct transfer of genetic materials to the target cells, it could exert functions on the level of genes and molecules. It is hoped to be widely used in the treatment of liver disease, especially hepatic tumors by using different vectors encoding the aim gene for anti-tumor activity by activating primary and adaptive immunity, inhibiting oncogene and angiogenesis. Despite the huge curative potential shown in animal models and some pilot clinical trials, gene therapy has been under fierce discussion since its birth in academia and the public domain because of its unexpected side effects and ethical problems. There are other challenges arising from the technique itself like vector design, administration route test and standard protocol exploration. How well we respond will decide the fate of gene therapy clinical medical practice.</description><subject>Animals</subject><subject>Diffusion of Innovation</subject><subject>Genetic Therapy - adverse effects</subject><subject>Genetic Therapy - ethics</subject><subject>Genetic Therapy - legislation & jurisprudence</subject><subject>Genetic Therapy - trends</subject><subject>Genetic Vectors</subject><subject>Government Regulation</subject><subject>Humans</subject><subject>Liver Diseases - genetics</subject><subject>Liver Diseases - therapy</subject><subject>Liver Neoplasms - genetics</subject><subject>Liver Neoplasms - therapy</subject><subject>Review</subject><subject>Transduction, Genetic</subject><subject>Treatment Outcome</subject><subject>基因治疗</subject><subject>带菌者</subject><subject>肝疾病</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNpVkc1u1DAURi0EosPAij2yEGIDGfwbO5tKqIJSUQkJwdpynJuMh4wztZ1WfZU-S9-JV8CjGQFdeeGjc797P4ReUrLiSugPN5thRcWKccIfoQVjtKmYFuQxWlBCVNVwpk7Qs5Q2hDDOJXuKTqgWtBZSLNDXcwiA8xqi3d3-vr_D32GYR5v9FNJ7DHntXcI2dNjnhHfRuuydHX32kLAPePTXEHHnE9gEz9GT3o4JXhzfJfr5-dOPsy_V5bfzi7OPl5UTXOaqV7SVjVAcFGE167Xqpexq0XdgeUOYslIy61pKndCgFaGFYiWvK6v0reNLdHrw7uZ2C52DkKMdzS76rY23ZrLePPwJfm2G6dowRSTRrAjeHAQ3NvQ2DGYzzTGUyKbckhGiqdzfaoneHufE6WqGlM3WJwfjaANMczJ1Q4uN1QV8dwBdnFKK0P_NQonZd7T3GirMvqNCv_o__j_2WEoBXh916ykMV74EbK371fsRygq01lRp_geiPJk7</recordid><startdate>20080421</startdate><enddate>20080421</enddate><creator>Jin, Xi</creator><creator>Yang, Yi-Da</creator><creator>Li, You-Ming</creator><general>Digestive Department, The First Affiliated Hospital, Medical School, Zhejiang University, Hangzhou 310003,Zhejiang Province, China%China Yi-Da Yang, Infectious disease Department, The First Affiliated Hospital, Medical School, Zhejiang University, Hangzhou 310003,Zhejiang Province, China</general><general>The WJG Press and Baishideng</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope><scope>5PM</scope></search><sort><creationdate>20080421</creationdate><title>Gene therapy: Regulations, ethics and its practicalities in liver disease</title><author>Jin, Xi ; Yang, Yi-Da ; Li, You-Ming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-f71b59473e70262f87f55d64fdea39027a552acb11c48e87012622164c932fbc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Diffusion of Innovation</topic><topic>Genetic Therapy - adverse effects</topic><topic>Genetic Therapy - ethics</topic><topic>Genetic Therapy - legislation & jurisprudence</topic><topic>Genetic Therapy - trends</topic><topic>Genetic Vectors</topic><topic>Government Regulation</topic><topic>Humans</topic><topic>Liver Diseases - genetics</topic><topic>Liver Diseases - therapy</topic><topic>Liver Neoplasms - genetics</topic><topic>Liver Neoplasms - therapy</topic><topic>Review</topic><topic>Transduction, Genetic</topic><topic>Treatment Outcome</topic><topic>基因治疗</topic><topic>带菌者</topic><topic>肝疾病</topic><toplevel>online_resources</toplevel><creatorcontrib>Jin, Xi</creatorcontrib><creatorcontrib>Yang, Yi-Da</creatorcontrib><creatorcontrib>Li, You-Ming</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>维普中文期刊数据库</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jin, Xi</au><au>Yang, Yi-Da</au><au>Li, You-Ming</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gene therapy: Regulations, ethics and its practicalities in liver disease</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2008-04-21</date><risdate>2008</risdate><volume>14</volume><issue>15</issue><spage>2303</spage><epage>2307</epage><pages>2303-2307</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>Gene therapy is a new and promising approach which opens a new door to the treatment of human diseases. By direct transfer of genetic materials to the target cells, it could exert functions on the level of genes and molecules. It is hoped to be widely used in the treatment of liver disease, especially hepatic tumors by using different vectors encoding the aim gene for anti-tumor activity by activating primary and adaptive immunity, inhibiting oncogene and angiogenesis. Despite the huge curative potential shown in animal models and some pilot clinical trials, gene therapy has been under fierce discussion since its birth in academia and the public domain because of its unexpected side effects and ethical problems. There are other challenges arising from the technique itself like vector design, administration route test and standard protocol exploration. How well we respond will decide the fate of gene therapy clinical medical practice.</abstract><cop>United States</cop><pub>Digestive Department, The First Affiliated Hospital, Medical School, Zhejiang University, Hangzhou 310003,Zhejiang Province, China%China Yi-Da Yang, Infectious disease Department, The First Affiliated Hospital, Medical School, Zhejiang University, Hangzhou 310003,Zhejiang Province, China</pub><pmid>18416454</pmid><doi>10.3748/wjg.14.2303</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1007-9327 |
ispartof | World journal of gastroenterology : WJG, 2008-04, Vol.14 (15), p.2303-2307 |
issn | 1007-9327 2219-2840 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2705082 |
source | PubMed Central |
subjects | Animals Diffusion of Innovation Genetic Therapy - adverse effects Genetic Therapy - ethics Genetic Therapy - legislation & jurisprudence Genetic Therapy - trends Genetic Vectors Government Regulation Humans Liver Diseases - genetics Liver Diseases - therapy Liver Neoplasms - genetics Liver Neoplasms - therapy Review Transduction, Genetic Treatment Outcome 基因治疗 带菌者 肝疾病 |
title | Gene therapy: Regulations, ethics and its practicalities in liver disease |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T11%3A42%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gene%20therapy%EF%BC%9A%20Regulations,%20ethics%20and%20its%20practicalities%20in%20liver%20disease&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Jin,%20Xi&rft.date=2008-04-21&rft.volume=14&rft.issue=15&rft.spage=2303&rft.epage=2307&rft.pages=2303-2307&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.14.2303&rft_dat=%3Cwanfang_jour_pubme%3Ewjg200815002%3C/wanfang_jour_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c435t-f71b59473e70262f87f55d64fdea39027a552acb11c48e87012622164c932fbc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69108226&rft_id=info:pmid/18416454&rft_cqvip_id=27168178&rft_wanfj_id=wjg200815002&rfr_iscdi=true |